Clinical Trials Sponsored by Sumitomo Pharma America, Inc.
Total 114 results
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States, Serbia, Colombia, Bulgaria, Russian Federation, Ukraine
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.Active, not recruitingGlioblastoma Multiforme | High Grade GliomaUnited States, Japan
-
Sumitomo Pharma America, Inc.TerminatedSarcoma | Ewing Sarcoma | Advanced Solid Tumors | Synovial Sarcoma | Dedifferentiated LiposarcomaUnited States
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.Terminated
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.CompletedGlioblastomaUnited States, Canada
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.CompletedCancerCanada, United States
-
Sumitomo Pharma America, Inc.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLLUnited States
-
Sumitomo Pharma America, Inc.TerminatedMyelodysplastic Syndromes (MDS)United States
-
Sumitomo Pharma America, Inc.TerminatedAcute Myeloid Leukemia (AML)United States
-
Sumitomo Pharma America, Inc.CompletedOncologyUnited States, Taiwan, Japan, France
-
Sumitomo Pharma America, Inc.RecruitingGeneralized Anxiety DisorderUnited States, Spain, Japan, Bulgaria, Estonia, Finland, Slovakia, Sweden
-
Sumitomo Pharma America, Inc.RecruitingLeukemia, Myeloid, Acute | Leukemia, Lymphocytic, AcuteJapan, United States
-
Sumitomo Pharma America, Inc.Active, not recruiting
-
Sumitomo Pharma America, Inc.TerminatedSchizophreniaUnited States, Serbia, Ukraine, Croatia, Colombia, Russian Federation, Bulgaria, Latvia
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States, Romania, Russian Federation, Ukraine
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States, Serbia, Croatia, Bulgaria, Latvia, Russian Federation, Ukraine
-
Sumitomo Pharma America, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States
-
Sumitomo Pharma America, Inc.CompletedCarcinoma, Pancreatic DuctalUnited States, France, Netherlands, Spain, Taiwan, China, Belgium, Korea, Republic of, Austria, Singapore, Japan, Italy, Germany, Portugal, Poland, Czechia, Australia, Canada, Russian Federation, Ukraine
-
Sumitomo Pharma America, Inc.CompletedAdvanced Gastrointestinal CancerUnited States, Canada
-
Sumitomo Pharma America, Inc.CompletedColorectal CancerUnited States, Canada, Spain, Australia, China, Hong Kong, Israel, Czechia, France, Japan, Belgium, Germany, Netherlands, Italy, Korea, Republic of, Singapore
-
Sumitomo Pharma America, Inc.CompletedGastric Cancer | Gastroesophageal Junction CancerUnited States, Hungary, Spain, China, Brazil, France, Australia, Czechia, Germany, Israel, Canada, United Kingdom, Japan, Belgium, Romania, Italy, Poland, Lithuania, Korea, Republic of, Bulgaria, Estonia, Russian Federation
-
Sumitomo Pharma America, Inc.CompletedGlioblastomaUnited States, Korea, Republic of, Taiwan, Canada, Japan
-
Sumitomo Pharma America, Inc.CompletedCancerUnited States, Canada
-
Sumitomo Pharma America, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Sumitomo Pharma America, Inc.TerminatedCancer | Ovarian CancerUnited States
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
Sumitomo Pharma America, Inc.CompletedHepatocellular Carcinoma | CholangiocarcinomaCanada
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
Sumitomo Pharma America, Inc.RecruitingMyelofibrosisUnited States, Japan, Australia
-
Sumitomo Pharma America, Inc.TerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Urothelial Carcinoma | Renal Cell Carcinoma (RCC) | Platinum-resistant Ovarian Cancer (PROC) | Serous Epithelial Ovarian CancerUnited States, Canada
-
Sumitomo Pharma America, Inc.CompletedSchizophreniaUnited States
-
Sumitomo Pharma America, Inc.Active, not recruiting
-
Sumitomo Pharma America, Inc.Enrolling by invitation
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.TerminatedDepressive Episodes, Bipolar I DepressionUnited States, Bulgaria, Japan
-
Sumitomo Pharma America, Inc.CompletedParkinson DiseaseUnited States, Spain, United Kingdom, Italy, Canada, Austria, France, Germany
-
Sumitomo Pharma America, Inc.TerminatedDepressive Episodes, Bipolar I DepressionUnited States, Bulgaria, Japan, Romania, Canada, Slovakia
-
Sumitomo Pharma America, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Spain, Canada, United Kingdom
-
Sumitomo Pharma America, Inc.CompletedHepatocellular CarcinomaUnited States
-
Sumitomo Pharma America, Inc.TerminatedGastrointestinal Stromal TumorsCanada
-
Sumitomo Pharma America, Inc.Completed
-
Sumitomo Pharma America, Inc.WithdrawnRenal Cell Carcinoma | Urothelial Carcinoma | Urologic Malignancies
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced Solid TumorsUnited States, Canada
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid TumorsUnited States
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States